Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Charbon pulmonaire d’origine bioterroriste: les 10 premiers cas rapportés aux Etats-Unis

John A. Jernigan*, David S. Stephens*†, David A. Ashford*, Carlos Omenaca‡, Martin S. Topiel§, Mark Galbraith¶, Michael Tapper#, Tamara L. Fisk*†, Sherif Zaki*, Tanja Popovic*, Richard F. Meyer*, Conrad P. Quinn*, Scott A. Harper*, Scott K. Fridkin*, James J. Sejvar*, Colin W. Shepard*, Michelle McConnell*, Jeannette Guarner*, Wun-Ju Shieh*, Jean M. Malecki**, Julie L. Gerberding*, James M. Hughes*, Bradley A. Perkins*, and members of the Anthrax Bioterrorism Investigation Team

Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA;; †Emory University School of Medicine, Atlanta, Georgia, USA;; ‡Cedars Medical Center, Miami, Florida, USA;; §Virtua Health, Mount Holly, New Jersey, USA;; ¶Winchester Medical Center, Winchester, Virginia, USA;; #Lenox Hill Hospital, New York City, New York, USA;; **Palm Beach County Department of Public Health, West Palm Beach, Florida, USA


Article in English

l'Article Principal

Tableau 2

Symptoms for 10 patients with bioterrorism-related inhalational anthrax, October - November 2001

Symptômes n=10
Fièvre, frissons 10
Sueurs, souvent profuses 7
Fatigue, malaise, léthargie 10
Toux (légère ou improductive) 9
Nausées ou vomissements 9
Dyspnée 8
Gêne  thoracique ou  douleurs de type pleurétique 7
Myalgies 6
Maux de tête 5
Etat confusionnel 4
Douleurs abdominales 3
Maux de gorge 2
Rhinorrhée 1

l'Article Principal

1Members of the team who contributed to the work presented in this manuscript are J. Aguilar, M. Andre, K. Baggett, B. Bell, D. Bell, M. Bowen, G. Carlone, M. Cetron, S. Chamany, B. De, C. Elie, M. Fischer, A. Hoffmaster, K. Glynn, R. Gorwitz, C. Greene, R. Hajjeh, T. Hilger, J. Kelly, R. Khabbaz, A. Khan, P. Kozarsky, M. Kuehnert, J. Lingappa, C. Marston, J. Nicholson, S. Ostroff, T. Parker, L. Petersen, R. Pinner, N. Rosenstein, A. Schuchat, V. Semenova, S. Steiner, F. Tenover, B. Tierney, T. Uyeki, S. Vong, D. Warnock, C. Spak, D. Jernigan, C. Friedman, M. Ripple, D. Patel, S. Pillai, S. Wiersma, R. Labinson, L. Kamal, E. Bresnitz, M. Layton, G. DiFerdinando, S. Kumar, P. Lurie, K. Nalluswami, L. Hathcock, L. Siegel, S. Adams, I. Walks, J. Davies-Coles, M. Richardson, K. Berry, E. Peterson, R. Stroube, H. Hochman, M. Pomeranz, A. Friedman-Kien, D. Frank, S. Bersoff-Matcha, J. Rosenthal, N. Fatteh, A. Gurtman, R. Brechner, C. Chiriboga, J. Eisold, G. Martin, K. Cahill, R. Fried, M. Grossman, and W. Borkowsky.

Haut de Page

Page created: August 04, 2011
Page updated: August 04, 2011
Page reviewed: August 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

LATEST PODCAST

Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b Infections in Wild Terrestrial Mammals, United States, 2022— (Length: 30:05)

 

Get Email Updates

To receive email updates about this page, enter your email address:

What's this?
Connect and Share
Additional CDC Resources
file_external